CanaQuest Medical Corp. Share Price Other OTC
Equities
CANQF
CA1372201097
Pharmaceuticals
Sales 2017 | - | Sales 2018 | - | Capitalization | 14.94L 12Cr |
---|---|---|---|---|---|
Net income 2017 | -20L -17Cr | Net income 2018 | -10L -8.35Cr | EV / Sales 2017 | - |
Net Debt 2017 | 91.34T 76.3L | Net Debt 2018 | 2L 1.28Cr | EV / Sales 2018 | - |
P/E ratio 2017 |
-1.01
x | P/E ratio 2018 |
-1.17
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 43.35% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Ramsay
CEO | Chief Executive Officer | 64 | 07/08/07 |
Richard Rusiniak
FOU | Founder | 75 | 07/08/07 |
Ross Eastley
DFI | Director of Finance/CFO | 76 | 01/09/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rusiniak
FOU | Founder | 75 | 07/08/07 |
Paul Ramsay
CEO | Chief Executive Officer | 64 | 07/08/07 |
W. McDonald
BRD | Director/Board Member | 58 | 28/14/28 |
1st Jan change | Capi. | |
---|---|---|
+29.76% | 568.52Cr | |
-32.34% | 353.38Cr | |
-2.23% | 305.91Cr | |
-25.26% | 261.68Cr | |
-10.88% | 228.7Cr | |
+40.09% | 186.14Cr | |
+40.90% | 143.23Cr | |
-15.16% | 140.98Cr | |
+42.86% | 140.15Cr |